METHOD AND APPARATUS FOR DETECTION AND AUTO-INJECTION

Smart overview of the Invention

The patent application describes a delivery device designed to monitor an individual's biometric data, such as heart rate and blood oxygen levels. When these biometric indicators fall below a predetermined threshold, the device triggers alerts to medical professionals and the individual's contacts, providing their location. If a medical condition like an opioid overdose is detected, the device administers a medicament, such as an opioid antagonist, through intramuscular or subcutaneous injection.

Background

Opioid Use Disorder (OUD) is a significant global issue, with millions affected worldwide. The opioid epidemic has led to increasing numbers of fatal overdoses, exacerbated by the isolation experienced by many individuals suffering from OUD. Illegally manufactured opioids often contain dangerous amounts of synthetic substances like fentanyl, raising the risk of fatal overdoses. Symptoms of an overdose include drowsiness and slowed breathing, necessitating prompt intervention with opioid antagonists like naloxone.

Device Components

The delivery device comprises several key components housed within a compact structure. It includes a processing module with monitoring and sensing capabilities for biometric data collection, and an administration module that stores and delivers the medicament. The administration module features a reservoir for the medicament, a cannula for transport, and an insertion mechanism that pierces the skin to deliver the drug effectively.

Functionality

Upon detecting a potential overdose condition through biometric monitoring, the device activates an alarm system that can produce auditory, vibratory, or optical signals. If not manually deactivated via a delay injection button, the device proceeds to inject the medicament automatically. The system continues administering the drug until disabled by a medical professional or as long as it detects a need based on ongoing biometric data analysis.

Embodiments

The patent outlines various embodiments of the device's components and functionalities. These include different configurations for the insertion mechanism (e.g., needle or trocar), attachment methods for the patch (e.g., adhesive fabric), and types of sensors used (e.g., PPG sensor or accelerometer). The medicament may include opioid antagonists like naloxone or partial antagonists such as buprenorphine. The device's design aims to ensure timely medical intervention during overdose situations, even when individuals are alone.